| Charles A. Dinarello Keynote Speaker, Professor, Univ. of Colorado Health Sciences Center
Paul Burton
Director, Amgen Inc.
Stephan J. O’Keefe
Senior Research Fellow, Merck Research Laboratories
Kathy Banner
Pfizer Inc.
James Karras
Director, Isis Pharmaceuticals
Garth Ringheim
Principal Scientist, Immunology Department, Aventis Pharmaceuticals
Alan Lewis
President, Celgene San Diego
Peter Kiener
Vice President, Med Immune
Garth Ringheim
Principal Scientist, Aventis Pharmaceuticals
Peter Kiener
Vice President, Medimmune
Henry Hess
Biogen Idec
Simon Blake
Johnson & Johnson
Margaret Karow
Vice President, Regeneron Pharmaceuticals
Teresa Cachero
Biogen Idec
Thomas Schall
President and CEO, ChemoCentryx, Inc.
Lawrence M. Blatt
Vice President, Applied Research, InterMune, Inc.
Julian A. Symons
Head, HCV Biology, Principal Research Scientist Viral Diseases Therapeutic Area, Roche Bioscience
Patricia Podolin
GlaxoSmithKline
|